Intco Medical Technology Co., Ltd.
300677
Rangering i aksjer
#3957
Intco Medical Technology Co., Ltd. is a company dedicated to the development,... Intco Medical Technology Co., Ltd. is a company dedicated to the development, manufacturing, and worldwide distribution of both single-use medical products and durable medical equipment, serving markets within China and internationally. Their extensive product portfolio includes a variety of personal protective equipment like gloves, face masks, and shields, as well as essential clinical supplies such as ECG electrodes, medical apparel (e.g., isolation gowns), and hand hygiene solutions in both gel and spray forms. The company also produces specialized surgical components, including grounding pads, electrosurgical pencils, ESU cables, tip cleaners, and TENS electrodes. Beyond disposables, Intco Medical supplies a range of robust medical devices, notably mobility aids such as wheelchairs and scooters, along with other general medical apparatus. Their offerings further extend to temperature therapy items, emergency treatment provisions, products for maternal and infant care, and various home healthcare solutions. Established in 2009 and headquartered in Zibo, China, the company underwent a formal corporate name update in January 2020, maintaining its designation as Intco Medical Technology Co., Ltd.
Aksjekurs
$6.36
Markedsverdi
$4.16B
Endring (1 dag)
-0.12%
Endring (1 år)
8.75%
Land
CN
Handel Intco Medical Technology Co., Ltd. (300677)
Kategori
Healthcare
P/E-forhold for Intco Medical Technology Co., Ltd. (300677)
P/E-forhold per October 2026 TTM: 24.48
Ifølge Intco Medical Technology Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 24.48. Ved slutten av 2023 hadde selskapet en P/E på 41.05.
P/E-forholdshistorikk for Intco Medical Technology Co., Ltd. fra 2013 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 24.48 | 118.79% |
| 2024 | 11.19 | -72.75% |
| 2023 | 41.05 | 92.51% |
| 2022 | 21.32 | 403.22% |
| 2021 | 4.24 | -10.96% |
| 2020 | 4.76 | -73.85% |
| 2019 | 18.20 | 20.80% |
| 2018 | 15.07 | -46.92% |
| 2017 | 28.39 | 14.32% |
| 2016 | 24.83 | -15.47% |
| 2015 | 29.38 | -40.48% |
| 2014 | 49.35 | -66.42% |
| 2013 | 146.96 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 47.48 | 93.95% |
US
|
|
| 27.43 | 12.02% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 132.38% |
US
|
|
| - | - |
CH
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.